I could pluck out 50 publicly traded companies on the OTC and Nasdaq trading at higher market caps that aren’t profitable. I could also pluck out a good amount that have similar or even less revenue than RXMD and that aren’t profitable trading at a higher market cap. You also predicted “carnage” the day after the new funding facility was announced.. what happened with that? Most of RXMD’s losses last year came via derivative liability expense — which is merely a paper loss. But thanks for your concerns nevertheless! Super happy to be a shareholder here!